ALENDRONATE SODIUM
Substance profile for UNII 2UY4M2U3RA, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.
Structure render from NCI/CADD chemical resolverSubstance Identity#
- UNII
- 2UY4M2U3RA
- Preferred term
- ALENDRONATE SODIUM
- Registry number
- 121268-17-5
- Ingredient type
- INGREDIENT SUBSTANCE
- Molecular formula
- C4H12NO7P2.Na.3H2O
Chemical And Database Identifiers#
- InChIKey
- DCSBSVSZJRSITC-UHFFFAOYSA-M
- SMILES
- O.O.O.[Na+].NCCCC(O)(P(O)(O)=O)P(O)([O-])=O
- RxCUI
- 203152
- PubChem
- 0
- NCIt
- C973
- INN ID
- 0
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| ALENDRONATE SODIUM | ACTIVE INGREDIENT | 2UY4M2U3RA | These highlights do not include all the information needed to use alendronate sodium tablets USP safely and effectively. See full prescribing information for alendronate sodium tablets USP. ALENDRONATE sodium tablets USP for oral use Initial U.S. Approval: 1995 | 1 | |
| ALENDRONATE SODIUM | ACTIVE INGREDIENT | 2UY4M2U3RA | These highlights do not include all the information needed to use Alendronate Sodium Tablets USP safely and effectively. See full prescribing information for Alendronate Sodium Tablets USP. ALENDRONATE Sodium Tablets USP for oral use Initial U.S. Approval: 1995 | 1 | |
| ALENDRONATE SODIUM | ACTIVE INGREDIENT | 2UY4M2U3RA | These highlights do not include all the information needed to use Alendronate Sodium Tablets USP safely and effectively. See full prescribing information for Alendronate Sodium Tablets USP. ALENDRONATE Sodium Tablets USP for oral use Initial U.S. Approval: 1995 | 1 | |
| ALENDRONATE SODIUM | ACTIVE INGREDIENT | 2UY4M2U3RA | These highlights do not include all the information needed to use alendronate sodium tablets USP safely and effectively. See full prescribing information for alendronate sodium tablets USP. ALENDRONATE sodium tablets USP for oral use Initial U.S. Approval: 1995 | 5 | |
| ALENDRONATE SODIUM | ACTIVE INGREDIENT | 2UY4M2U3RA | ALENDRONATE SODIUM TABLETS USP 5140 5141 5172 5142 5171 Rx only | 4 | |
| alendronate sodium | ACTIVE INGREDIENT | 2UY4M2U3RA | These highlights do not include all the information needed to use FOSAMAX PLUS D safely and effectively. See full prescribing information for FOSAMAX PLUS D. FOSAMAX ® PLUS D (alendronate sodium/cholecalciferol) tablets Initial U.S. Approval: 2005 | 2 | |
| alendronate sodium | ACTIVE INGREDIENT | 2UY4M2U3RA | ALENDRONATE SODIUM TABLETS, USP | 1 | |
| ALENDRONATE SODIUM | ACTIVE INGREDIENT | 2UY4M2U3RA | e6ffadda-2ace-4e99-8bb4-75631c54f39b | 1 | |
| ALENDRONATE SODIUM | ACTIVE INGREDIENT | 2UY4M2U3RA | ALENDRONATE SODIUM TABLETS, USP | 1 | |
| ALENDRONATE SODIUM | ACTIVE INGREDIENT | 2UY4M2U3RA | FOSAMAX (ALENDRONATE SODIUM) TABLET [MERCK SHARP & DOHME CORP.] | 32 | |
| ALENDRONATE SODIUM | ACTIVE INGREDIENT | 2UY4M2U3RA | FOSAMAX PLUS D (ALENDRONATE SODIUM AND CHOLECALCIFEROL) TABLET [MERCK SHARP & DOHME CORP.] | 25 | |
| ALENDRONATE SODIUM | ACTIVE INGREDIENT | 2UY4M2U3RA | ALENDRONATE SODIUM TABLET [ACTAVIS PHARMA, INC.] | 22 | |
| ALENDRONATE SODIUM | ACTIVE INGREDIENT | 2UY4M2U3RA | ALENDRONATE SODIUM TABLET [TEVA PHARMACEUTICALS USA INC] | 18 | |
| ALENDRONATE SODIUM | ACTIVE INGREDIENT | 2UY4M2U3RA | ALENDRONATE SODIUM TABLET [AUROBINDO PHARMA LIMITED] | 15 | |
| ALENDRONATE SODIUM | ACTIVE INGREDIENT | 2UY4M2U3RA | ALENDRONATE SODIUM TABLET [MYLAN PHARMACEUTICALS INC.] | 14 | |
| ALENDRONATE SODIUM | ACTIVE INGREDIENT | 2UY4M2U3RA | ALENDRONATE SODIUM TABLET [BLU PHARMACEUTICALS, LLC] | 13 | |
| ALENDRONATE SODIUM | ACTIVE INGREDIENT | 2UY4M2U3RA | ALENDRONATE SODIUM (ALENDRONATE SODIUM ) TABLET [APOTEX CORP.] | 8 | |
| Alendronate Sodium | ACTIVE INGREDIENT | 2UY4M2U3RA | ALENDRONATE SODIUM (ALENDRONATE SODIUM) TABLET [JUBILANT CADISTA PHARMACEUTICALS INC.] | 8 | |
| ALENDRONATE SODIUM | ACTIVE INGREDIENT | 2UY4M2U3RA | ALENDRONATE SODIUM TABLET [MYLAN INSTITUTIONAL INC.] | 7 | |
| ALENDRONATE SODIUM | ACTIVE INGREDIENT | 2UY4M2U3RA | ALENDRONATE SODIUM TABLET [NORTHSTAR RX LLC] | 7 | |
| ALENDRONATE SODIUM | ACTIVE INGREDIENT | 2UY4M2U3RA | ALENDRONATE SODIUM TABLET [SUN PHARMA GLOBAL INC.] | 7 | |
| alendronate sodium | ACTIVE INGREDIENT | 2UY4M2U3RA | BINOSTO (ALENDRONATE SODIUM) TABLET, EFFERVESCENT [MISSION PHARMACAL COMPANY] | 7 | |
| ALENDRONATE SODIUM | ACTIVE INGREDIENT | 2UY4M2U3RA | ALENDRONATE SODIUM TABLET [WATSON LABORATORIES, INC.] | 6 | |
| ALENDRONATE SODIUM | ACTIVE INGREDIENT | 2UY4M2U3RA | ALENDRONATE SODIUM TABLET [SUN PHARMA GLOBAL FZE] | 3 | |
| ALENDRONATE SODIUM | ACTIVE INGREDIENT | 2UY4M2U3RA | ALENDRONATE (ALENDRONATE SODIUM) TABLET [VIRTUS PHARMACEUTICALS] | 1 | |
| Alendronate Sodium | ACTIVE INGREDIENT | 2UY4M2U3RA | ALENDRONATE SODIUM SOLUTION [TAGI PHARMA, INC.] | 1 | |
| ALENDRONATE SODIUM | ACTIVE INGREDIENT | 2UY4M2U3RA | ALENDRONATE SODIUM TABLET [CIPLA USA INC.] | 1 | |
| ALENDRONATE SODIUM | ACTIVE INGREDIENT | 2UY4M2U3RA | ALENDRONATE SODIUM TABLET [GOLDEN STATE MEDICAL SUPPLY, INC.] | 1 | |
| ALENDRONATE SODIUM | ACTIVE INGREDIENT | 2UY4M2U3RA | ALENDRONATE SODIUM TABLET [PREFERRED PHARMACEUTICALS, INC.] | 1 | |
| ALENDRONATE SODIUM | ACTIVE INGREDIENT | 2UY4M2U3RA | ALENDRONATE SODIUM TABLET [PROFICIENT RX LP] | 1 | |
| ALENDRONATE SODIUM | ACTIVE INGREDIENT | 2UY4M2U3RA | ALENDRONATE SODIUM TABLET [PROFICIENT RX LP] | 1 | |
| ALENDRONATE SODIUM | ACTIVE INGREDIENT | 2UY4M2U3RA | ALENDRONATE SODIUM TABLET [REMEDYREPACK INC. ] | 1 | |
| ALENDRONATE SODIUM | ACTIVE INGREDIENT | 2UY4M2U3RA | ALENDRONATE SODIUM TABLET [REMEDYREPACK INC. ] | 1 | |
| ALENDRONATE SODIUM | ACTIVE INGREDIENT | 2UY4M2U3RA | ALENDRONATE SODIUM TABLET [REMEDYREPACK INC. ] | 1 | |
| ALENDRONATE SODIUM | ACTIVE INGREDIENT | 2UY4M2U3RA | ALENDRONATE SODIUM TABLET [VIRTUS PHARMACEUTICALS] | 1 | |